Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)

ClinicalTrials.gov ID: NCT00000174

Public ClinicalTrials.gov record NCT00000174. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 7:27 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Study identification

NCT ID
NCT00000174
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis
Industry
Enrollment
Not listed

Conditions and interventions

Interventions

  • Rivastigmine Drug

Drug

Eligibility (public fields only)

Age range
55 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Not listed
Primary completion
Not listed
Completion
Not listed
Last update posted
Jun 23, 2005

United States locations

U.S. sites
15
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
Medici Research Centers Peoria Arizona 85381
University of California, Irvine Orange California 92868
University of Colorado Health Sciences Center Denver Colorado 80220
Neuromedical Research Institute (Offices in Ft. Lauderdale, Miami Beach and Boca Raton) Fort Lauderdale Florida 33321
Miami Research Associates Miami Florida 33176
Center for Clinical Trials and Research Venice Florida 34285
Indiana University Alzheimer's Center Indianapolis Indiana 46202
St. Louis University St Louis Missouri 63104
Alzheimer's Research Corporation Lakewood New Jersey 08701
NYU Medical Center New York New York 10016
Duke University Medical Center Durham North Carolina 27710
Pahl Brain Associates, P.C. Oklahoma City Oklahoma 73118
Clinical Studies, Ltd., Philadelphia Philadelphia Pennsylvania 19106
St. Paul Medical Center Dallas Texas 75235
University of Washington, Seattle Seattle Washington 98108

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000174, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 23, 2005 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000174 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →